Published in J Nucl Cardiol on December 28, 2000
The impact of quantitative imaging in medicine and surgery: Charting our course for the future. Quant Imaging Med Surg (2011) 1.13
Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease. Am J Nucl Med Mol Imaging (2014) 0.79
Issues in quantification of cardiac PET studies. Eur J Nucl Med Mol Imaging (2007) 0.75
Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J (2008) 2.21
Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol (1990) 2.20
Noninvasive delineation of the effects of moderate aging on myocardial perfusion. J Nucl Med (1991) 2.07
beta-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart. Eur J Nucl Med (1989) 1.96
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
Resting coronary flow and coronary flow reserve in human infants after repair or palliation of congenital heart defects as measured by positron emission tomography. J Thorac Cardiovasc Surg (1998) 1.73
Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol (1990) 1.65
Bronchial artery embolisation can be equally safe and effective in the management of chronic recurrent haemoptysis. Hong Kong Med J (2008) 1.63
Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. J Nucl Med (1995) 1.61
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med (1984) 1.57
Management of patients admitted with pneumothorax: a multi-centre study of the practice and outcomes in Hong Kong. Hong Kong Med J (2009) 1.47
Effects of time discrepancies between input and myocardial time-activity curves on estimates of regional myocardial perfusion with PET. J Nucl Med (1994) 1.47
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J Nucl Med (1991) 1.46
Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O. J Am Coll Cardiol (1990) 1.44
Failure of right precordial electrocardiography during stress testing to identify coronary artery disease. J Nucl Cardiol (2001) 1.42
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Am Coll Cardiol (1990) 1.42
Exponential analysis of elastic recoil and aging in healthy males and females. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.40
Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax (2003) 1.40
Myocardial viability--what is the definition? J Nucl Med (1991) 1.39
Incidence of major cardiovascular events in black patients with normal myocardial stress perfusion study results. J Nucl Cardiol (2001) 1.38
Measurement of myocardial blood flow with PET using 1-11C-acetate. J Nucl Med (2001) 1.33
Influence of cardiac and respiratory motion on tomographic reconstructions of the heart: implications for quantitative nuclear cardiology. J Comput Assist Tomogr (1982) 1.31
Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry (1997) 1.31
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Quantification of regional myocardial blood flow in vivo with H215O. Circulation (1984) 1.24
Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science (1983) 1.22
Alveolar size as a determinant of pulmonary distensibility in mammalian lungs. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.22
Dual-[11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab (2001) 1.20
The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med (1987) 1.16
Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J (1996) 1.14
Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation (1987) 1.13
Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label. Circulation (1992) 1.13
Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry (1997) 1.08
Use of an exponential function for elastic recoil. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.08
Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med (1989) 1.08
Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. J Clin Invest (1984) 1.06
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation (1984) 1.06
An improved isolated heart preparation for external assessment of myocardial metabolism. Am J Physiol (1979) 1.05
Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction. J Nucl Med (2001) 1.04
Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum (1998) 1.04
Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res (1992) 1.04
The super PET 3000-E: a PET scanner designed for high count rate cardiac applications. J Comput Assist Tomogr (1994) 1.02
Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J Cardiovasc Surg (Torino) (2005) 1.01
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism (1999) 1.01
Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med (1989) 1.00
Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation (1990) 1.00
Identification of fatty acid ethyl esters as products of rabbit myocardial ethanol metabolism. J Biol Chem (1981) 1.00
Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation (1985) 1.00
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99
Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically. Circ Res (1985) 0.99
Two cases of intraperitoneal bladder rupture following vaginal delivery. Singapore Med J (2008) 0.98
Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol (1988) 0.98
Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol (1987) 0.98
Phosphorylation of glucose analog 3-O-methyl-D-glucose by rat heart. Biochem Biophys Res Commun (1984) 0.97
Normal limits for left ventricular ejection fraction and volumes estimated with gated myocardial perfusion imaging in patients with normal exercise test results: influence of tracer, gender, and acquisition camera. J Nucl Cardiol (2000) 0.97
Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol (1992) 0.97
Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol (1992) 0.96
Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol (1998) 0.96
Absolute quantitation of coronary steal induced by intravenous dipyridamole. J Am Coll Cardiol (2001) 0.96
The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology (2004) 0.96
Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA). Biochem Pharmacol (1984) 0.94
Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol (1994) 0.94
Transmural gradients of coronary flow reserve with physiologically and morphometrically defined stenoses in dogs. Am Heart J (1989) 0.94
The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion. Circulation (1980) 0.94
Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4. Am J Physiol Heart Circ Physiol (2001) 0.92
Decreased pulmonary distensibility and pulmonary barotrauma in divers. Respir Physiol (1991) 0.91
Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am J Physiol (1981) 0.91
Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. J Comput Assist Tomogr (1989) 0.91
Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol (1993) 0.90
Pleuroscopy: our initial experience in Hong Kong. Hong Kong Med J (2008) 0.90
Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol (1991) 0.87
Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. J Nucl Med (1996) 0.87
Pulmonary distensibility and ventilatory function in smokers. Bull Eur Physiopathol Respir (1986) 0.87
An improved assay with 4-(2-thiazolylazo)-resorcinol for non-esterified fatty acids in biological fluids. Clin Chim Acta (1980) 0.87
Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. J Nucl Med (1987) 0.87
Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency). Am J Cardiol (1993) 0.86
Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia (2013) 0.86
Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. Circulation (2000) 0.86
Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation (1990) 0.86
Characterization of the functional significance of subcritical coronary stenoses with H(2)15O and positron-emission tomography. Circulation (1985) 0.86
Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. J Nucl Med (1989) 0.86
Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer (1995) 0.86
Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate. Circulation (1981) 0.85
Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate. Circulation (1982) 0.84
Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol (1993) 0.84
Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem (1996) 0.84
Noninvasive detection of coronary thrombi with In-111 platelets: concise communication. J Nucl Med (1983) 0.84
Computerized measurement of pulmonary conductance and elastic recoil. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.84
Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med (1989) 0.84
Protection of ischemic myocardium in diabetics by inhibition of electroneutral Na+-K+-2Cl- cotransporter. Am J Physiol Heart Circ Physiol (2001) 0.83
Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart. Nucl Med Biol (1998) 0.83
A longitudinal study of pulmonary distensibility in healthy adults. Respir Physiol (1986) 0.83
Kinetics of positron emitters in vivo characterized with a beta probe. Am J Physiol (1982) 0.83
Quantitation of benzodiazepine receptor binding with PET [11C]iomazenil and SPECT [123I]iomazenil: preliminary results of a direct comparison in healthy human subjects. Psychiatry Res (1999) 0.83
Assessment of blood flow distal to coronary artery stenoses. Correlations between myocardial positron emission tomography and poststenotic intracoronary Doppler flow reserve. Circulation (1996) 0.82
Use of wavelet transforms in analysis of time-activity data from cardiac PET. J Nucl Med (2001) 0.82
Validation of 3-deoxy-3-fluoro-D-glucose as a glucose transport analogue in rat heart. Am J Physiol (1984) 0.82